| Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732) |
|---|
| 04/03/2013 | CN103012266A Preparation method of 7-chloro-5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine |
| 04/03/2013 | CN103012265A Preparation method of 7-chloro-5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine |
| 04/03/2013 | CN103012264A Method for resolving 3-substituted amino-hexahydro-1H-azacycloheptane |
| 04/03/2013 | CN103012263A Method for preparing caprolactam |
| 04/03/2013 | CN103012262A Caprolactam production method |
| 04/03/2013 | CN103007870A Nozzle impinging stream rearrangement reactor |
| 04/03/2013 | CN103007869A Three liquid phase material feeding nozzle for caprolactam rearrangement reaction |
| 04/03/2013 | CN102120729B Industrial method for producing iminostilbene through catalytic dehydrogenation of iminodibenzyl |
| 03/27/2013 | EP2572716A1 Anti-inflammatory Composition |
| 03/27/2013 | CN103003259A Processes for the production of hydrogenated products and derivatives thereof |
| 03/27/2013 | CN103003245A Processes for the production of hydrogenated products and derivatives thereof |
| 03/27/2013 | CN102993095A Seven-element-ring polyhydroxy nitrone and preparation method and application thereof |
| 03/27/2013 | CN102989185A Production system of dehydrated caprolactam and method thereof |
| 03/27/2013 | CN102146051B Method for separating amide from amino acid ionic liquid |
| 03/26/2013 | US8404675 Benzazepine derivatives and methods of prophylaxis or treatment of 5HT2C receptor associated diseases |
| 03/26/2013 | CA2731315C Novel method for the synthesis of ivabradine and the addition salts thereof with a pharmaceutically acceptable acid |
| 03/21/2013 | WO2013040471A2 Noribogaine salt ansolvates |
| 03/21/2013 | WO2013038864A1 Mist separation device and reaction system |
| 03/21/2013 | WO2012156987A3 Novel process for preparation of eslicarbazepine |
| 03/21/2013 | CA2845007A1 Noribogaine salt ansolvates |
| 03/20/2013 | CN102985408A Processes for producing caprolactam and derivatives thereof from fermentation broths containing diammonium adipate, monoammonium adipate and/or adipic acid |
| 03/20/2013 | CN102977025A (-)-meptazinol phenylamino carbamate-L-(+)-tartrate type-III crystal |
| 03/20/2013 | CN102977024A (-)-meptazinol phenylamino carbamate-L-(+)-tartrate type-I crystal |
| 03/20/2013 | CN102977023A (-)-meptazinol phenylamino carbamate-L-(+)-tartrate type-III crystal |
| 03/20/2013 | CN102977022A (-)-meptazinol phenyl carbamate-L-(+)-tartrate IV type crystal |
| 03/19/2013 | US8399681 Substituted aminothiazolone indazoles as estrogen related receptor-alpha modulators |
| 03/14/2013 | WO2013008194A3 Process for the preparation and purification of eslicarbazepine acetate and intermediates thereof |
| 03/13/2013 | EP2566850A1 Industrial process for the synthesis of ivabradine salts |
| 03/13/2013 | CN102971298A Processes for producing caprolactam and derivatives thereof from fermentation broths containing diammonium adipate or monoammonium adipate |
| 03/13/2013 | CN101528671B MTP inhibiting tetrahydro-naphthalene-1-carboxylic acid derivatives |
| 03/12/2013 | US8394372 Stabilized protease composition |
| 03/12/2013 | CA2517077C Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 03/07/2013 | US20130059838 Substituted n-heteroaryl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof |
| 03/06/2013 | EP2563761A1 Activators of human pyruvate kinase |
| 03/06/2013 | CN102958909A Metal free bleaching composition |
| 03/06/2013 | CN102958906A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 03/06/2013 | CN102952075A Synthetic method of caprolactam |
| 03/06/2013 | CN102950022A Catalyst composition and method for preparing amide |
| 03/06/2013 | CN102039179B Catalytic component for preparing amide and method for preparing amide |
| 03/05/2013 | US8389522 Modulators of aldehyde dehydrogenase and methods of use thereof |
| 03/05/2013 | CA2529320C Benzazepine derivatives useful for the treatment of 5ht2c receptor associated diseases |
| 02/28/2013 | WO2013028664A1 Psma imaging agents |
| 02/28/2013 | WO2013026455A1 Permanently positively charged antidepressants |
| 02/27/2013 | EP2560634A1 Nitric oxide releasing prodrugs of therapeutic agents |
| 02/27/2013 | CN102212033B Method for lowering caprolactam inclusion content in ammonium sulfate crystals |
| 02/21/2013 | WO2013024400A1 Improved method for quantitative determination of ivabradine hydrochloride |
| 02/20/2013 | CN202741130U 一种己内酰胺加氢反应釜 One kind of caprolactam hydrogenation reactor |
| 02/14/2013 | WO2013022047A1 Cyclopropaneamine compound |
| 02/14/2013 | US20130041146 Asymmetric Catalytic Reduction of Oxcarbazepine |
| 02/14/2013 | CA2844525A1 Cyclopropaneamine compound |
| 02/13/2013 | CN202730054U Caprolactam monomer recovery system for high-volume production of polyamide slice |
| 02/13/2013 | CN102933530A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 02/13/2013 | CN102924333A Preparation and application of ionic liquid used for absorbing low-boiling halohydrocarbon gas |
| 02/13/2013 | CN102924217A Fluorene and pyrene derivatives and organic electroluminescent device using the same |
| 02/13/2013 | CN101851205B New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid |
| 02/13/2013 | CN101851204B New process for the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid |
| 02/12/2013 | CA2576257C Anti-inflammatory agents |
| 02/07/2013 | WO2013017937A1 Process for the manufacture of ivabradine and of intermediates of synthesis thereof |
| 02/07/2013 | WO2013017582A1 Acetone solvate of ivabradine hydrochloride |
| 02/07/2013 | CA2843553A1 Process for the manufacture of ivabradine and of intermediates of synthesis thereof |
| 02/06/2013 | CN102911118A Benzo-azepine type derivative and preparation method and purpose thereof |
| 02/05/2013 | US8367821 Preparation of eslicarbazepine and related compounds by asymmetric hydrogenation |
| 02/05/2013 | US8367820 Optically active ammonium salt compound, production intermediate thereof, and production method thereof |
| 02/05/2013 | US8367657 Processes for preparing 3-benzazepines |
| 01/31/2013 | US20130030146 Preparation of caprolactam from 6-amino caproic acid obtained in a fermentation process |
| 01/30/2013 | CN102895996A Catalytic system for Beckmann rearrangement of oxime |
| 01/24/2013 | WO2013012829A1 Diaminocyclohexane compounds and uses thereof |
| 01/24/2013 | WO2012120356A3 Process for the preparation of (s)-(+)-or (r)-(-)-10 hydroxy dihydrodibenz[b,f]azepines by enantioselective reduction of 10, 11-dihydro-10-oxo-5h-dibenz[b,f]azepines and polymorphs thereof |
| 01/22/2013 | CA2550053C Tetrahydrobenzazepines and their use in the modulation of the dopamine d3 receptor |
| 01/17/2013 | WO2013008194A2 Process for the preparation and purification of eslicarbazepine acetate and intermediates thereof |
| 01/17/2013 | US20130018044 New inhibitors of cyclophilins and uses thereof |
| 01/16/2013 | CN102875469A Method for preparing caprolactam through adopting radial moving bed reactor |
| 01/16/2013 | CN102875468A Method for producing caprolactam through gas phase rearrangement of cyclohexanone-oxime |
| 01/10/2013 | US20130012701 Quaternary heteroatom containing compounds |
| 01/10/2013 | US20130012699 Amidium-based ionic liquids for carbon dioxide absorption |
| 01/10/2013 | US20130012498 5ht2c receptor modulators |
| 01/10/2013 | US20130012495 5ht2c receptor modulators |
| 01/10/2013 | US20130012485 Organic compounds |
| 01/10/2013 | US20130009136 Triphenylene-based compounds and organic electroluminescent device comprising same |
| 01/09/2013 | EP2542523A1 Method of manufacturing epsilon-caprolactam |
| 01/09/2013 | CN102863385A Method for directly synthesizing caprolactam through cyclohexanone |
| 01/09/2013 | CN102863384A Method of utilizing micro-reactor to prepare caprolactam by cyclohexanone oxime |
| 01/09/2013 | CN102863383A Preparation method of oxygen bleaching activator tribasic copper chloride (TBCC) |
| 01/09/2013 | CN102863382A Solvent recovery method of caprolactam rearrangement reaction products and application thereof |
| 01/08/2013 | CA2546653C 3-aminopyrrolidone derivatives |
| 01/03/2013 | WO2012116151A3 Vinyl -aryl - sulfones for use in peritoneal carcinomatosis |
| 01/02/2013 | CN102850273A Novel synthesizing method of (R)-alpha-amino-epsilon-caprolactam |
| 01/02/2013 | CN101801377B Anti-inflammatory composition |
| 01/02/2013 | CN101613311B System and method for reclaiming hexanolactam from rearrangement mixture |
| 12/27/2012 | WO2012175962A1 COMPOUNDS FOR USE IN STABILISING p53 MUTANTS |
| 12/26/2012 | CN102838541A Preparation method for intermediate II during meptazinol hydrochloride synthesis process |
| 12/20/2012 | WO2012173214A1 Azepane compound |
| 12/19/2012 | EP2535333A1 Generically binding antibodies with multiple applications |
| 12/19/2012 | EP2534135A2 Novel forms of ivabradine hydrochloride |
| 12/19/2012 | EP2534134A1 Low viscosity ionic liquids |
| 12/19/2012 | CN102827080A Novel synthetic method of ivabradine and novel intermediate product of ivabradine |
| 12/19/2012 | CN102827019A One group of novel benzene cyclobutane compounds and application of novel benzene cyclobutane compounds in chemical synthesis |
| 12/13/2012 | US20120316153 Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 12/12/2012 | CN101967107B Method of manufacturing benzoazepin compound or its salt |
| 12/12/2012 | CN101486677B 5HT2C receptor modulators |